Vertex Pharmaceuticals invests in scientific innovation to discover, develop, and produce medicines that transform lives for people with serious diseases. The company focuses on specialty markets, bringing together world-class talent, cutting-edge science, and calculated risk-taking to strike at the core of complex conditions. From cystic fibrosis to sickle cell disease, type 1 diabetes, and kidney diseases, Vertex channels most resources back into research and development. With headquarters in Boston and London, and global sites advancing cell therapies, gene editing, and non-opioid pain treatments, the company turns scientific possibility into medical breakthroughs.
6400
Team Members
1989
Founded
Pharma
Sector
Hybrid
Work Environment
A world where serious diseases no longer limit human potential, where scientific possibility becomes reality for every person waiting for a cure.
At Vertex, our mission is to create transformative medicines for people with serious diseases with a focus on specialty markets.